During the past decade, Rothhaar Studien GmbH conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rothhaar Studien GmbH" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Amgen" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rothhaar Studien GmbH" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Bioskin GmbH" with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Rothhaar Studien GmbH" are "Psoriasis" (6 trials), "Plaque Psoriasis" (4 trials), "Atopic Dermatitis" (3 trials), "Dermatitis, Atopic" (2 trials) and "Chronic Spontaneous Urticaria" (1 trials). Many other conditions were trialed in "Rothhaar Studien GmbH" in a lesser frequency.

Most popular intervention types in "Rothhaar Studien GmbH" are "Drug" (17 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BI 695501" (2 trials), "Baricitinib" (2 trials), "JNJ-77242113" (2 trials) and "PF-06700841" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rothhaar Studien GmbH" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Rothhaar Studien GmbH". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Rothhaar Studien GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rothhaar Studien GmbH, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".